Scientists at pharma companies thought: GLP-1 is interesting
TL;DR: Our Verdict MEDVi is a budgetforward, cashpay GLP1 program that leans on compounded medication and markets a simple hook: low first month , locked refill price , and lose weight or your money back. If youre comfortable with compounded meds and want 24/7 support, it can be a fit
Although it displays a very similar pharmacological profile to that of exenatide, lixisenatide is given once-daily with a dose of 10 or 20 g
The degradation by DPP-4 of exenatide and liraglutide and DPP-4 inhibitors (sitagliptin, saxagliptin, vildagliptin and linagliptin) currently represents an effective therapeutic option for patients with type 2 diabetes
We were not able to perform in silico replication, as there are currently no HT cohorts of Caucasian origin with available GWAS data and measures for both thyroid antibodies (TPOAb and TgAb)
Safety considerations for compounded GLP-1 medications Not all compounding pharmacies are equal